Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ·Healthcare·Biotechnology
$3.44
-1.43%
Mkt Cap $384.11M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | $277.78K | — | — | -$0.42 | -$0.38 | +9.52% | — | — |
| Q4 2025 Nov 6, 2025 | $312.50K | — | — | -$0.48 | -$0.45 | +6.25% | — | — |
| Q3 2025 Aug 7, 2025 | $4.36M | — | — | -$0.57 | -$0.59 | -3.51% | — | — |
| Q2 2025 May 8, 2025 | $800.00K | — | — | -$0.59 | -$0.56 | +5.08% | — | — |
| Q1 2025 Feb 27, 2025 | $28.45K | — | — | -$0.68 | -$0.62 | +8.82% | — | — |
| Q4 2024 Nov 7, 2024 | $34.78K | — | — | -$0.78 | -$0.71 | +8.97% | — | — |
| Q3 2024 Aug 5, 2024 | — | — | — | -$0.74 | -$0.74 | +0.00% | — | — |
| Q2 2024 May 6, 2024 | $110.00K | — | — | -$0.69 | -$0.66 | +4.35% | — | — |
| Q1 2024 Feb 26, 2024 | — | $10.31M | — | -$0.80 | -$0.64 | +20.00% | — | — |
| Q4 2023 Nov 6, 2023 | — | — | — | -$0.82 | -$0.75 | +8.54% | — | — |
| Q3 2023 Aug 10, 2023 | — | — | — | -$0.80 | -$0.82 | -2.50% | — | — |
| Q2 2023 May 4, 2023 | — | — | — | -$0.86 | -$0.73 | +15.12% | — | — |
| Q1 2023 Feb 27, 2023 | $111.11K | — | — | -$0.81 | -$0.92 | -13.58% | — | — |
| Q4 2022 Nov 3, 2022 | — | — | — | -$0.77 | -$0.87 | -12.99% | — | — |
| Q3 2022 Aug 8, 2022 | — | — | — | -$0.68 | -$0.83 | -22.06% | — | — |
| Q2 2022 May 5, 2022 | — | — | — | -$0.70 | -$0.67 | +4.29% | — | — |
| Q1 2022 Feb 24, 2022 | — | — | — | -$0.75 | -$0.69 | +8.00% | — | — |
| Q4 2021 Nov 3, 2021 | — | — | — | -$0.58 | -$0.79 | -36.21% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$0.66 | -$0.55 | +16.67% | — | — |
| Q2 2021 May 10, 2021 | — | — | — | -$0.77 | -$0.65 | +15.58% | — | — |